Expanding Service Range CompuNet’s recent launch of advanced tests like Cystatin C with eGFR and Cellavision DC-1 indicates a focus on expanding diagnostic capabilities. This presents a sales opportunity to introduce complementary testing solutions, new technology integrations, and specialized laboratory assays to healthcare providers seeking comprehensive diagnostic options.

Direct-to-Consumer Growth The company's emphasis on accessible and affordable testing options without the need for physician referrals suggests a strong position in the direct-to-consumer market. Sales prospects include marketing partnerships, digital health platforms, and insurance providers looking to broaden consumer testing services.

Hospital Collaboration CompuNet’s established partnerships with hospitals like Premier Health and the launch of in-house testing for hospital patients show ongoing integration within healthcare infrastructure. Business development opportunities exist in expanding hospital contracts, offering remote laboratory solutions, and integrating lab data into electronic health records.

Technological Investment The company’s investment in emerging technologies such as AWS, Epic Citrix, and digital marketing tools demonstrates an innovative approach. This creates opportunities to offer cutting-edge lab solutions, data management services, and cloud-based analytics to healthcare institutions seeking modern diagnostic infrastructure.

Market Position & Potential With revenue estimates between $100 million and $250 million and a strategic focus on growth areas like COVID-19 testing and expanded diagnostics, CompuNet is well-positioned for sales expansion into specialty labs, health plans, and employer health programs aiming to enhance their diagnostic offerings and patient engagement.